How brain changes during perimenopause may affect Alzheimer's risk in women

Animal

NIH-funded research University of Arizona · NIH-11129675

This work looks at how brain and immune changes during perimenopause could raise Alzheimer's risk in midlife women using a humanized APOE animal model.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionUniversity of Arizona NIH-funded
Lab location1 site (Tucson, United States)
Project IDNIH-11129675 on NIH RePORTER

What this research studies

Researchers use a rodent model that mimics human perimenopause and carries human APOE genes to mirror key features of midlife female brain changes. The Animal Core maintains the animals, runs behavioral and physiological tests, delivers intervention regimens, and collects brain and other tissues. Samples and data are shared with analytic teams to search for immune and other brain changes that predict higher Alzheimer's risk. The goal is to find biological signs in midlife that might point to ways to prevent later Alzheimer's.

Who could benefit from this research

Good fit: Women in perimenopause or midlife who are concerned about Alzheimer's risk—especially those with known APOE risk variants—are most relevant to these findings.

Not a fit: People who are not female, not in midlife/perimenopause, or whose Alzheimer's risk is unrelated to APOE or perimenopausal biology may not directly benefit from these results.

Why it matters

Potential benefit: If successful, this work could identify midlife biological changes to target for preventing or delaying Alzheimer's in women.

How similar studies have performed: APOE-based animal models have been widely used to study Alzheimer's mechanisms, but applying a perimenopause-focused model to link midlife immune changes to later Alzheimer's risk is a relatively new approach.

Where this research is happening

Tucson, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease risk
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.